BIIB
BIOGEN INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$250.91
+0.79%Margins
Gross margin
70.0%
EBITDA margin
14.1%
EBIT margin
7.6%
Net margin
3.4%
FCF margin
22.8%
1.8%
Return on equity
1.1%
Return on assets
2.9%
Return on invested capital
0.32x
Asset turnover
$2.2B
Cash from operations
$8.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026